Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) CEO Jeffrey Hawkins sold 20,143 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $0.76, for a total value of $15,308.68. Following the transaction, the chief executive officer directly owned 3,649,659 shares in the company, valued at approximately $2,773,740.84. This represents a 0.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Jeffrey Alan Hawkins also recently made the following trade(s):
- On Tuesday, September 22nd, Jeffrey Hawkins sold 9,709 shares of Quantum-Si stock. The stock was sold at an average price of $0.76, for a total value of $7,378.84.
Quantum-Si Stock Up 3.5%
NASDAQ QSI opened at $0.79 on Friday. Quantum-Si Incorporated has a 52 week low of $0.69 and a 52 week high of $3.10. The firm has a market capitalization of $171.82 million, a price-to-earnings ratio of -1.71 and a beta of 3.25. The company has a fifty day moving average of $0.77 and a two-hundred day moving average of $0.88.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on QSI. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Wall Street Zen upgraded Quantum-Si from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Finally, Weiss Ratings downgraded Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, September 9th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $1.00.
Check Out Our Latest Stock Report on QSI
Institutional Trading of Quantum-Si
Several institutional investors and hedge funds have recently made changes to their positions in the company. IPG Investment Advisors LLC purchased a new position in Quantum-Si during the 2nd quarter valued at about $27,000. WINTON GROUP Ltd bought a new position in shares of Quantum-Si during the second quarter valued at approximately $67,000. Corient Private Wealth LP purchased a new position in Quantum-Si during the second quarter valued at approximately $34,000. Green Alpha Advisors LLC bought a new position in Quantum-Si in the second quarter worth approximately $41,000. Finally, Renaissance Technologies LLC bought a new position in Quantum-Si in the first quarter worth approximately $91,000. 39.90% of the stock is currently owned by institutional investors.
Quantum-Si Company Profile
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.
Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.
Featured Articles
- Five stocks we like better than Quantum-Si
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
